Dalton presently serves as CEO/President. Mr. Shaull’s ‘Connected Purpose’ stems from his personal experiences including a near-fatal automobile accident and a recipient of an experimental transplant at Mayo Clinic as a result. Mr. Shaull also brings a network of hospitals, surgeons, administrators, and investors to the business including key relationships at transplant hospitals across the US and leads business development efforts toward expanding their services across the care continuum of organ transplantation to drive outcomes, reduce cost, and provide the optimal experience for transplant clinicians and their patients.
Rethinking Organ Intake: The Effects of Allocation Changes and Staffing Shortages on Clinical Productivity
The impact of the new organ allocation system and the ongoing effects of the pandemic has significantly shifted the way transplant centers operate from a clinical and business management perspective. During this webinar, we will be joined by leaders throughout the country who will discuss the current challenges surrounding organ intake management and recovery, as well as various clinical operational models. Additionally, they will share key insights, solutions, and effective practices they’ve identified to successfully navigate the new transplant landscape.